Literature DB >> 2406015

Differences in the biosynthesis and localization of the fibronectin receptor in normal and transformed cultured human cells.

S K Akiyama1, H Larjava, K M Yamada.   

Abstract

We examined the biosynthesis and localization of the fibronectin receptor integrin from normal and transformed cultured human cells. Normal cells required a minimum of 20 h for the biosynthesis of completely mature fibronectin-receptor beta-subunit, while transformed cells required only 6-8 h. There was a correspondingly major decrease in the amount of the intracellular beta-chain precursor in the transformants. Immunostaining of normal fibroblastic cells with monoclonal antibodies indicated that both alpha- and beta-polypeptides of the fibronectin receptor are localized in cell surface streaks and focal contact areas. In contrast, both subunits lacked this clustering and had a more diffuse distribution on the surfaces of transformed cells, even though quantitative immunofluorescence experiments indicated that similar or larger amounts of each subunit were present on a per cell basis. Both immunostaining and biochemical analyses also indicated the presence of a relatively large intracellular pool of beta-polypeptides in normal fibroblasts that is not present in transformed cells. There was no major transformation-dependent change in total quantities of mature fibronectin receptor subunit expressed and inserted into the plasma membrane, when normalized to total protein synthesis. Our results indicate that malignant transformation of cultured human cells results in altered localization and processing of the fibronectin receptor. Such changes involving pathways of crucial cell surface molecules may contribute to alterations in their interactions with extracellular macromolecules, including during the process of cellular invasion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2406015

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Growth suppression of transformed cells by a human placental extract not related to transforming growth factor beta.

Authors:  J L Klein; E Hamel; J L Tayot; H Yamasaki
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

2.  Focal adhesion kinase (FAK) phosphorylation is not required for genistein-induced FAK-beta-1-integrin complex formation.

Authors:  Y Liu; E Kyle; R Lieberman; J Crowell; G Kellof; R C Bergan
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

3.  The size of the intracellular beta 1-integrin precursor pool regulates maturation of beta 1-integrin subunit and associated alpha-subunits.

Authors:  L Koivisto; J Heino; L Häkkinen; H Larjava
Journal:  Biochem J       Date:  1994-06-15       Impact factor: 3.857

4.  Altered expression of extracellular matrix molecules and their receptors in chronic pancreatitis and pancreatic adenocarcinoma in comparison with normal pancreas.

Authors:  S Shimoyama; F Gansauge; S Gansauge; T Oohara; H G Beger
Journal:  Int J Pancreatol       Date:  1995-12

5.  Stimulation of beta1-integrin function by epidermal growth factor and heregulin-beta has distinct requirements for erbB2 but a similar dependence on phosphoinositide 3-OH kinase.

Authors:  M A Adelsman; J B McCarthy; Y Shimizu
Journal:  Mol Biol Cell       Date:  1999-09       Impact factor: 4.138

6.  Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo.

Authors:  M L Nierodzik; A Plotkin; F Kajumo; S Karpatkin
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

Review 7.  Fibronectin and integrins in invasion and metastasis.

Authors:  S K Akiyama; K Olden; K M Yamada
Journal:  Cancer Metastasis Rev       Date:  1995-09       Impact factor: 9.264

8.  Expression and ligand binding of alpha 2 beta 1 integrin on breast carcinoma cells.

Authors:  M Maemura; S K Akiyama; V L Woods; R B Dickson
Journal:  Clin Exp Metastasis       Date:  1995-07       Impact factor: 5.150

9.  Integrin distributions in renal cell carcinomas of various grades of malignancy.

Authors:  M Korhonen; L Laitinen; J Ylänne; G K Koukoulis; V Quaranta; H Juusela; V E Gould; I Virtanen
Journal:  Am J Pathol       Date:  1992-11       Impact factor: 4.307

10.  Distribution of integrin cell adhesion molecules in endometrial cancer.

Authors:  B A Lessey; S Albelda; C A Buck; A J Castelbaum; I Yeh; M Kohler; A Berchuck
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.